Images List Premium Download Classic

Infectious

Infectious-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Light-emitting versions of the monoclonal antibody to c3d (mab 3d29) for imaging
The John Hopkins University
October 12, 2017 - N°20170290930

The presently disclosed subject matter provides compositions and kits comprising light-emitting versions of the monoclonal antibody to c3d (mab 3d29) for imaging and methods of use thereof for detecting infectious and inflammatory cells in vivo. The presently disclosed subject matter also provides methods for detecting and/or monitoring a mycobacterium tuberculosis (m. Tuberculosis) infection in a subject, as well ...
Activation of adaptive immune processes for the treatment of cancers and infectious diseases
Susavion Biosciences, Inc.
October 12, 2017 - N°20170290922

Polypeptides, such as a multi-valent polypeptide designated svd2, useful in pharmaceutical compositions for stimulation of the adaptive arm of the immune system. Svd2 demonstrated in vivo activity in a syngeneic mouse model. Svd2 is biologically active at nanomolar concentrations. These properties are believed to result as a consequence of the ability of svd2 to cross-link cell-surface receptors.
Pyrazolopyrimidine compounds
Susavion Biosciences, Inc.
October 12, 2017 - N°20170290910

Wherein r1 is n-c1-6alkyl or c1-2alkoxyc1-2alkyl-, r2 is halo, oh or c1-3alkyl, m is an integer having a value of 4, 5, 6 or 7, n is an integer having a value of 0, 1, 2 or 3, and p is an integer having a value of 0, 1 or 2, are inducers of human interferon. Compounds which induce human interferon may be ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for rapidly determining effective sterilization , deimmunization, and/or disinfection
Oneightyºc Technologies Corporation
October 05, 2017 - N°20170283847

A method for rapidly determining effective sterilization, deimmunization, and/or disinfection of equipment and/or supplies by a device. The method includes providing a defined surrogate protein having a predetermined sequence representative of an infectious agent potentially contaminating the equipment and/or the supplies to be sterilized, deimmunized, and/or disinfected by the device. The defined surrogate protein having the ...
Immunomodulators
Bristol-myers Squibb Company
October 05, 2017 - N°20170283463

The present disclosure provides novel macrocyclic peptides which inhibit the pd-1/pd-l1 and pd-l1/cd80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Immunomodulators
Bristol-myers Squibb Company
October 05, 2017 - N°20170283462

The present disclosure provides novel macrocyclic peptides which inhibit the pd-1/pd-l1 and pd-l1/cd80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Antibodies to tigit
Abmuno Therapeutics Llc
October 05, 2017 - N°20170281764

The invention provides monoclonal antibodies that specifically bind to tigit. The monoclonal antibodies have the capacity for substantial activation of t cells and natural killer cells by inhibiting binding of tigit to cd155. The monoclonal antibodies can be used for treatment of cancer and infectious disease, among other applications.
Pooled nk cells from umbilical cord blood associated with antibodies and their uses for the ...
Emercell Sas
October 05, 2017 - N°20170281681

The invention relates to the field of cell therapy, particularly nk cell mediated therapy associated with antibodies. The present invention is directed to methods and compositions for increasing the efficiency of therapeutic natural killer cells (nk cells) and/or antibodies, wherein said methods or compositions comprise the use of pooled nk cells from umbilical cord blood units (ucbs), preferably alloreactive ...
Multiplex immuno screening assay
Institut Pasteur
September 28, 2017 - N°20170276672

The present invention provides kits and assay methods for the early detection of pathogens, precise identification of the etiologic agent, and improved disease surveillance. More specifically, the present invention discloses an immunoassay leading to the rapid and simultaneous detection of antibodies to a wide range of infectious pathogens in biological fluids of infected patients. This immunoassay involves the covalent and ...
Benzazepine sulfonamide compounds
Institut Pasteur
September 28, 2017 - N°20170275253

Wherein r4 or r5 is —so2—nr7r8 and r1 to r8 and y are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are tlr agonists and may therefore be useful as medicaments for the treatment of diseases such as cancer, autoimmune diseases, inflammation, sepsis, allergy, asthma, graft ...
Method for analyzing health signal to respond to infectious disease and apparatus thereof
Samsung Electronics Co., Ltd.
September 21, 2017 - N°20170270262

A method and an apparatus for analyzing a biosignal to respond to an infectious disease are provided. An analyzing method involves receiving biosignals of users of terminals and location information of the terminals, determining infectiousness of a condition of a user among the users by analyzing the location information and the biosignals, and transmitting feedback information regarding the infectiousness of ...
Production method for pluripotent stem cells having antigen-specific t cell receptor gene
Samsung Electronics Co., Ltd.
September 21, 2017 - N°20170267972

(2) inducing t cell progenitors or mature t cells from the pluripotent stem cells provided in step (1). Pluripotent stem cells may preferably be ips cells. The human pluripotent stem cells bearing a t cell receptor specific for an antigen may be prepared by inducing ips cells from a t cell having the desired antigen specificity or by introducing genes encoding the ...
Methionine analogs and methods of using same
Bioxiness Pharmaceuticals, Inc.
September 21, 2017 - N°20170267632

Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and/or antiviral properties. Also provided are methods of treatment and methods of preparation, as well as kits and unit dosages.
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Pharmaceutical formulations that form gel in situ
Iview Therapeutics, Inc.
September 21, 2017 - N°20170266294

The present invention provides aqueous formulations containing an anti-infection agent, a biocompatible polysaccharide, an osmotic pressure regulator, a ph regulator, and water, wherein a gel containing the therapeutic agent is formed in situ upon instillation of the formulations onto the skin and a body cavity of a subject. The formulations of this invention are useful for treating infectious diseases of ...
A novel synergistic herbal formulation for degenerative disease cardiovascular diseases, autoimmune, inflammatory and metabolism disorder ...
Iview Therapeutics, Inc.
September 21, 2017 - N°20170266247

The present invention relates to a novel synergistic herbal formulation for degenerative disease, cardiovascular diseases, autoimmune, inflammatory and infectious diseases and metabolism disorder etc. Of man, animal and plants more particularly, the present invention relates to the herbal formulation for degenerative disease, cardiovascular diseases, autoimmune, inflammatory and infectious diseases etc which is prepared by using preparation of pongamia pinnata, dalbergia ...
Prevention and treatment of microbial infections
Matoke Holdings Limited
September 21, 2017 - N°20170266240

Compositions for prevention and treatment of microbial infectious, such as microbial infections that comprise a biofilm, or a microbe that is capable of forming a biofilm are described. The compositions comprise an enzyme that is able to convert a substrate to release hydrogen peroxide and a substance that includes a substrate for the enzyme. The enzyme is additional to any ...
Cell growth method and pharmaceutical preparation for tissue repair and regeneration
Sapporo Medical University
September 21, 2017 - N°20170266234

The present invention relates to a method for growing, rapidly and massively ex vivo, cells collected from a living subject to provide a safe and effective pharmaceutical preparation for biological tissue repair/regeneration. Specifically, the present invention relates to a method for growing cells in a sample collected from a living subject by culturing the cells in a medium containing ...
Drug delivery system and method of treating ocular diseases in animals
Sapporo Medical University
September 21, 2017 - N°20170266110

The present invention relates in general to the field of drug delivery systems for treating ocular diseases in animals, and more specifically, to a drug delivery system and method of treating infectious bovine keratoconjunctivitis (“ibk”) in cattle, commonly known as “pinkeye.” the drug delivery system and method may include a contact lens ...
Methods and apparatus for rapid detection of infectious microorganisms
Becton, Dickinson And Company
September 14, 2017 - N°20170261464

An array of micro-chambers (220) with isfets (300) disposed therein for monitoring single cell activity in the microarray to determine the presence or absence of microorganisms in a sample (390).
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
Bristol-myers Squibb Company
September 14, 2017 - N°20170260237

The present disclosure provides novel macrocyclic peptides which inhibit the pd-1/pd-l1 and pd-l1/cd80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Thienopyrroles as histone demethylase inhibitors
Istituto Europeo Di Oncologia S.r.l.
September 14, 2017 - N°20170260197

The present application relates to thienopyrrole derivatives, compounds of formulas (i) and (ia), wherein r, r1, r2 and r3 are as defined in the specification, pharmaceutical compositions containing such compounds and to their use in therapy. The compounds of the application can be useful for inhibiting kdm1 and the prevention and/or treatment of cancer, infectious disease, or a disease ...
Loading